ArticleFrontiers in endocrinology2026
Altered umbilical cord adipokine profile associated with maternal obesity: an exploratory cohort study.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Maternal obesity is associated with adverse pregnancy outcomes and may influence fetal metabolic programming through alterations in the intrauterine environment. While leptin has been extensively investigated in pregnancies complicated by maternal obesity, the contribution of emerging adipokines, including neuregulin-4 (NRG4) and isthmin-1 (ISM1), to the fetal adipokine profile remains incompletely understood. This study aimed to characterize alterations in the umbilical cord blood adipokine profile associated with maternal obesity and to evaluate their relationship with early neonatal outcomes. Materials and methods: This prospective exploratory cohort study was conducted at Balıkesir University Faculty of Medicine Hospital, Balıkesir, Türkiye, and included 82 term singleton pregnancies delivered by cesarean section between March and May 2026. Participants were classified as obese (first-trimester BMI ≥30 kg/m², n=40) or non-obese (BMI <30 kg/m², n=42). Maternal demographic and biochemical characteristics, together with neonatal clinical outcomes, were recorded. Umbilical cord blood leptin, NRG4, and ISM1 concentrations were measured using enzyme-linked immunosorbent assay (ELISA). Between-group comparisons, partial correlation analysis, multivariate analysis of covariance (MANCOVA), and analysis of covariance (ANCOVA) were performed. Results: Maternal glucose concentrations were significantly higher, whereas neonatal glucose concentrations were significantly lower, in the obese group (p = 0.009 and p < 0.001, respectively). Compared with the non-obese group, cord blood leptin and ISM1 concentrations were significantly increased, while NRG4 concentrations were significantly decreased (all p < 0.05). MANCOVA demonstrated a significant overall effect of maternal obesity on the adipokine profile, with leptin contributing most strongly to this association. Following adjustment, leptin remained independently associated with maternal obesity (ANCOVA: p < 0.001, η² = 0.28), whereas ISM1 and NRG4 were no longer independently significant. Partial correlation analysis demonstrated positive associations among the investigated adipokines, with the strongest correlation observed between ISM1 and NRG4 (r = 0.88, p < 0.001). No significant differences were observed between the groups regarding neonatal complications, Apgar scores, umbilical cord blood pH, lactate, bilirubin concentrations, or neonatal intensive care unit admission. Conclusion: Maternal obesity was associated with an altered umbilical cord adipokine profile characterized by a robust increase in leptin together with coordinated alterations in emerging adipokines. Although these biochemical changes were not accompanied by differences in early neonatal outcomes, they may represent early metabolic adaptations to an obesogenic intrauterine environment. These findings support the potential role of cord blood adipokines as biomarkers of fetal metabolic programming and warrant confirmation in larger prospective longitudinal studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.